Similar mechanisms of fatty acid transfer from human anal rodent fatty acid-binding proteins to membranes: Liver, intestine, heart muscle and adipose tissue FABPs

Molecular and Cellular Biochemistry

Volumn 239, Issue 1-2, 2002, Pages 25-33

  Storch, Judith ^a   Veerkamp, Jacques H ^b   Hsu, Kuo Tung ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fatty acid; Fatty acid binding protein; Gene polymorphism; Lipid transport; Phospholipid membranes

Indexed keywords

ALANINE; FATTY ACID; FATTY ACID BINDING PROTEIN; THREONINE; CARRIER PROTEIN; FABP5 PROTEIN, MOUSE; FABP7 PROTEIN, HUMAN; FABP7 PROTEIN, MOUSE; FABP7 PROTEIN, RAT; NERVE PROTEIN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADIPOSE TISSUE; AMINO ACID SUBSTITUTION; ANIMAL CELL; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; FATTY ACID TRANSPORT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INTESTINE CELL; LIGAND BINDING; LIVER CELL; MOUSE; NONHUMAN; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; RAT; REVIEW; ANIMAL; ARTICLE; CELL MEMBRANE; GENETICS; HEART MUSCLE; INTESTINE; LIVER; METABOLISM; OSMOLARITY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALIA; MAMMALIA; RODENTIA;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL MEMBRANE; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; HUMANS; INTESTINES; LIVER; MICE; MYOCARDIUM; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; OSMOLAR CONCENTRATION; RATS; TUMOR SUPPRESSOR PROTEINS;

EID: 0036813338     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020546321508     Document Type: Review

References (41)

1. Storch J, Thumser AEA: The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 1486: 28-44, 2000
2. Glatz JFC, van der Vusse G: Cellular fatty acid-binding protoeins: Their function and physiological significance. Prog Lipid Res 35: 243-282, 1996
3. Kim HK, Storch J: Free fatty acid transfer from rat liver fatty acid-binding protein to phospholipid vesicles: Effect of ligand and solution properties. J Biol Chem 267: 77-82, 1992
4. Hsu KT, Storch J: Fatty acid transfer from liver and intestinal fatty acid binding-proteins to membranes occurs by different mechanisms. J Biol Chem 271: 13317-13323, 1996
5. Storch J, Bass NM: Transfer of fluorescent fatty acids from liver and heart fatty acid-binding proteins to model membranes. J Biol Chem 265: 7827-7831 ,1990
6. Wootan MG, Bernlohr DA, Storch J: Mechanism of fluorescent fatty acid transfer from adipocyte fatty acid binding protein to membrane. Biochemistry 32: 8622-8627, 1993
7. Wootan MG, Starch J: Regulation of fluorescent fatty acid transfer from adipocyte and heart fatty acid binding proteins by acceptor membrane lipid composition and structure. J Biol Chem 269: 10517-10523, 1994
8. Kim HK, Storch J: Mechanism of free fatty acid transfer from rat heart fatty acid binding protein to phospholipid membranes: Evidence for a collisional process. J Biol Chem 267: 20051-20056, 1992
9. Liou H, Storch J: The helical cap domain is important for fatty acid transfer from adipocyte and heart fatty acid-binding proteins to membranes. FASEB J 12: A514, 1998
10. Corsico B, Cistola DP, Frieden C, Storch J: The helical domain of intestinal fatty acid binding protein is critical for collisional transfer of fatty acids to phospholipid membranes. Proc Natl Acad Sci USA 95: 12174-12178,1998
11. Lion H-L, Storch J: Role of surface lysine residues of adipocyte fatty acid-binding protein in fatty acid transfer to phospholipid vesicles. Biochemistry 40: 6475-6485, 2001
12. Richieri GV, Low PJ, Ogata RT, Kleinfeld AM: Thermodynamics of fatty acid binding to engineered mutants of the adipocyte and intestinal fatty acid-binding proteins. J Biol Chem 273: 7397-7405, 1998
13. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, Prochazka M: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95: 1281-1287, 1995
14. Herr FM, Matarese V, Bernlohr DA, Storch J: Surface lysine residues modulate the collisional transfer of fatty acid from adipocyte fatty acid binding protein to membranes. Biochemistry 34: 11840-11845, 1995
15. Zimmerman AW, van Moerkerk HTB, Veerkamp JH: Ligand specificity and conformational stability of human fatty acid-binding proteins. Int J Biochem Cell Biol 33: 865-876, 2001
16. Veerkamp JH van Moerkerk HTB, Prinsen CFM, van Kuppevelt TH: Structural and functional studies on different human FABP types. Mol Cell Biochem 192: 137-142, 1999
17. Smith ER, Storch J: The adipocyte fatty acid-binding protein binds to membranes by electrostatic interactions. J Biol Chem 274: 35325-35330, 1999
18. Ames BN: Assay of inorganic phosphate, total phosphate and phosphatases. Meth Enzymol 8: 115-118, 1966
19. Herr FM, Aronson J, Storch J: Role of portal region lysine residues in electrostatic interactions between heart fatty acid binding protein and phospholipid membranes. Biochemistry 35: 1296-1303, 1996
20. Richieri GV, Ogata RT, Kleinfeld AM: Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J Biol Chem 269: 23918-23930, 1994
21. Charlton SC, Smith LC: Kinetics of transfer of pyrene and rac-1-oley1-2-[4-(3-pyrenyl)butanoyl]glycerol between human plasma lipoproteins. Biochemistry 21: 4023-4030, 1982
22. Zucker SD: Kinetic model of protein-mediated ligand transport: Influence of soluble binding proteins on the intermembrane diffusion of a fluorescent fatty acid. Biochemistry 40: 977-986, 2001
23. Weisiger RW, Zucker SD: Transfer of fatty acids between intracelluar membranes: Roles of soluble binding proteins, distance, and time. Am J Physiol 282: G105-G115, 2002
24. 54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 41:2002-2008, 2000
25. Agren JJ, Vidgren HM, Valve RS, Laakso M, Uusitupa MI Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am J Clin Nutr 73: 31-35, 2001
26. Georgopoulos A, Aras O, Tsai MY: Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab 85: 3155-3160, 2000
27. Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL: Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in african-americans: The atherosclerosis risk in communities study. Diabetes 48: 1868-1872, 1999
28. Tahvanainen E, Molin M, Vainio S, Tiret L, Nicaud V, Farinaro E, Masana L, Ehnholm C: Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young europeans. Results from EARS II participants. Atherosclerosis 152: 317-325, 2000
29. Levy E, Menard D, Delvin E, Stan S, Mitchell G, Lambert M, Ziv E, Feoli-Fonseca JC, Seidman E: The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem 276: 39679-39684, 2001
30. Vassileva G, Huwyler L, Poirier K, Agellon LBTMJ: The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J 14: 2040-2046, 2000
31. Baier LJ, Bogardus C, Sacchettini JC: A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 271: 10892-10896, 1996
32. Darimont C, Gradoux N, Persohn E, Cumin F, De Pover A: Effects of intestinal fatty acid-binding protein overexpression on fatty acid metabolism in Caco-2 cells. J Lipid Res 41: 84-92, 2000
33. Binas B, Danneberg H, McWhir J, Mullins L, Clark AJ: Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J 13: 805-812, 1999
34. -/- mice. Diabetes 48: 1987-1993, 1999
35. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS: Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141: 3388-3396, 2000
36. -/-) mice after short-term high-fat feeding. Diabetes 49: 904-911, 2000
37. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377-1379, 1996
38. Coe NR, Simpson MA, Bernlohr D: Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 40: 967-972, 1999
39. Perrella MA, Pellacani A, Layne MD, Patel A, Zhao D, Schreiber BM, Storch J, Feinberg MW, Hsieh CM, Haber E, Lee ME: Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J. 15: 1774-1776, 2001
40. Layne MD, Patel A, Chen YH, Rebel VI, Carvajal IM, Pellacani A, Ith B, Zhao D, Schreiber BM, Yet SF, Lee ME, Storch J, Perrella MA: Role of macrophage-expressed adipocyte fatty acid-binding protein in the development of accelerated atherolsclerosis in hypercholesterolemic mice. FASEB J 15: 2733-3735, 2001
41. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton ME: Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Med 7: 699-705, 2001